These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
422 related items for PubMed ID: 9426741
1. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system. Getzenberg RH, Light BW, Lapco PE, Konety BR, Nangia AK, Acierno JS, Dhir R, Shurin Z, Day RS, Trump DL, Johnson CS. Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741 [Abstract] [Full Text] [Related]
2. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089. Lokeshwar BL, Schwartz GG, Selzer MG, Burnstein KL, Zhuang SH, Block NL, Binderup L. Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302 [Abstract] [Full Text] [Related]
3. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer. Pinski J, Reile H, Halmos G, Groot K, Schally AV. Cancer Res; 1994 Jan 01; 54(1):169-74. PubMed ID: 7903203 [Abstract] [Full Text] [Related]
4. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells. Kubota T, Koshizuka K, Koike M, Uskokovic M, Miyoshi I, Koeffler HP. Cancer Res; 1998 Aug 01; 58(15):3370-5. PubMed ID: 9699668 [Abstract] [Full Text] [Related]
5. 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 and prostate cancer cell proliferation in vivo. Schwartz GG, Hill CC, Oeler TA, Becich MJ, Bahnson RR. Urology; 1995 Sep 01; 46(3):365-9. PubMed ID: 7660511 [Abstract] [Full Text] [Related]
6. In vivo antitumor activity of bropirimine against PAIII and Dunning MAT-LyLu rodent prostate cancers. Sarosdy MF, Higdon AL, Demoor CA. J Urol; 1996 Jun 01; 155(6):2085-9. PubMed ID: 8618341 [Abstract] [Full Text] [Related]
7. Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats. Chang CJ, Ghosh PK, Hu YF, Brueggemeier RW, Lin YC. Res Commun Chem Pathol Pharmacol; 1993 Mar 01; 79(3):293-312. PubMed ID: 8480076 [Abstract] [Full Text] [Related]
8. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555). George DJ, Dionne CA, Jani J, Angeles T, Murakata C, Lamb J, Isaacs JT. Cancer Res; 1999 May 15; 59(10):2395-401. PubMed ID: 10344749 [Abstract] [Full Text] [Related]
9. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines. Koike M, Koshizuka K, Kawabata H, Yang R, Taub HE, Said J, Uskokovic M, Tsuruoka N, Koeffler HP. Anticancer Res; 1999 May 15; 19(3A):1689-97. PubMed ID: 10470102 [Abstract] [Full Text] [Related]
10. An in vitro and in vivo study of antitumor effects of genistein on hormone refractory prostate cancer. Naik HR, Lehr JE, Pienta KJ. Anticancer Res; 1994 May 15; 14(6B):2617-9. PubMed ID: 7872690 [Abstract] [Full Text] [Related]
11. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Díaz GD, Paraskeva C, Thomas MG, Binderup L, Hague A. Cancer Res; 2000 Apr 15; 60(8):2304-12. PubMed ID: 10786699 [Abstract] [Full Text] [Related]
12. Effect of nucleoside analogue BCH-4556 on prostate cancer growth and metastases in vitro and in vivo. Rabbani SA, Harakidas P, Bowlin T, Attardo G. Cancer Res; 1998 Aug 01; 58(15):3461-5. PubMed ID: 9699681 [Abstract] [Full Text] [Related]
13. The antitumor effects of the quinoline-3-carboxamide linomide on Dunning R-3327 rat prostatic cancers. Ichikawa T, Lamb JC, Christensson PI, Hartley-Asp B, Isaacs JT. Cancer Res; 1992 Jun 01; 52(11):3022-8. PubMed ID: 1591718 [Abstract] [Full Text] [Related]
14. The effect of castanospermine on the metastatic properties of prostate cancer cells. Yee CS, Schwab ED, Lehr JE, Quigley M, Pienta KJ. Anticancer Res; 1997 Jun 01; 17(5A):3659-63. PubMed ID: 9413219 [Abstract] [Full Text] [Related]
15. Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system. Light BW, Yu WD, McElwain MC, Russell DM, Trump DL, Johnson CS. Cancer Res; 1997 Sep 01; 57(17):3759-64. PubMed ID: 9288784 [Abstract] [Full Text] [Related]
16. Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells. Tyagi A, Bhatia N, Condon MS, Bosland MC, Agarwal C, Agarwal R. Prostate; 2002 Nov 01; 53(3):211-7. PubMed ID: 12386921 [Abstract] [Full Text] [Related]
17. A calcitriol analogue, EB1089, inhibits the growth of LNCaP tumors in nude mice. Blutt SE, Polek TC, Stewart LV, Kattan MW, Weigel NL. Cancer Res; 2000 Feb 15; 60(4):779-82. PubMed ID: 10706079 [Abstract] [Full Text] [Related]
18. Pentosan inhibits angiogenesis in vitro and suppresses prostate tumor growth in vivo. Nguyen NM, Lehr JE, Pienta KJ. Anticancer Res; 1993 Feb 15; 13(6A):2143-7. PubMed ID: 7507655 [Abstract] [Full Text] [Related]
19. An orally active Amazonian plant extract (BIRM) inhibits prostate cancer growth and metastasis. Dandekar DS, Lokeshwar VB, Cevallos-Arellano E, Soloway MS, Lokeshwar BL. Cancer Chemother Pharmacol; 2003 Jul 15; 52(1):59-66. PubMed ID: 12734674 [Abstract] [Full Text] [Related]
20. Targeted cytotoxic analogue of somatostatin AN-238 inhibits growth of androgen-independent Dunning R-3327-AT-1 prostate cancer in rats at nontoxic doses. Koppan M, Nagy A, Schally AV, Arencibia JM, Plonowski A, Halmos G. Cancer Res; 1998 Sep 15; 58(18):4132-7. PubMed ID: 9751625 [Abstract] [Full Text] [Related] Page: [Next] [New Search]